Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Capital Reinvestment Ratio

Latest as of September 2025: 0.01x

Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.76 Million) in capital expenditures (CN¥3.59 Million). See 002424 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥294.76 Million
CNY

Capital Expenditures

CN¥3.59 Million
CNY

Data as of

Sep 2025
Most recent filing

Guizhou Bailing Group Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)

This chart tracks Guizhou Bailing Group Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)

Year-by-year Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see market value of Guizhou Bailing Group Pharmaceutical Co .

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.17x CN¥748.72 Million CN¥125.24 Million ▼ -96.4%
2024 4.66x CN¥9.02 Million CN¥42.02 Million ▲ +462.6%
2023 0.83x CN¥125.77 Million CN¥104.12 Million ▲ +507.3%
2022 0.14x CN¥502.15 Million CN¥68.45 Million ▼ -89.6%
2021 1.31x CN¥324.92 Million CN¥425.73 Million ▲ +237.3%
2020 0.39x CN¥231.78 Million CN¥90.02 Million ▲ +48.9%
2019 0.26x CN¥467.41 Million CN¥121.91 Million ▼ -85.6%
2017 1.81x CN¥79.88 Million CN¥144.68 Million ▲ +430.4%
2016 0.34x CN¥466.62 Million CN¥159.34 Million ▲ +16.6%
2015 0.29x CN¥413.23 Million CN¥121.04 Million ▲ +20.2%
2014 0.24x CN¥395.83 Million CN¥96.49 Million ▼ -61.1%
2013 0.63x CN¥141.76 Million CN¥88.74 Million ▼ -93.2%
2012 9.23x CN¥19.52 Million CN¥180.16 Million ▲ +865.3%
2011 0.96x CN¥201.90 Million CN¥193.07 Million ▲ +446.8%
2009 0.17x CN¥125.31 Million CN¥21.91 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow